This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:publications:albert_autoimmunity_reviews_2009 [04.24.2009] – neldawhite | home:publications:albert_autoimmunity_reviews_2009 [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | | ||
+ | |||
+ | **Type:** Paper\\ | ||
+ | **Authors: | ||
+ | **Publication: | ||
+ | **Citation: | ||
+ | |||
+ | |||
+ | < | ||
+ | |||
+ | <a href=" | ||
+ | </ | ||
+ | |||
+ | ===== Abstract ===== | ||
+ | |||
+ | |||
+ | |||
+ | Early studies on vitamin D showed promise that various forms of the “vitamin” may be protective against chronic disease, yet systematic reviews and longer-term studies have failed to confirm these findings. A number of studies have suggested that patients with autoimmune diagnoses are deficient in 25-hydroxyvitamin-D (25-D) and that consuming greater quantities of vitamin D, which further elevates 25-D levels, alleviates autoimmune disease symptoms. Some years ago, molecular biology identified 25-D as a secosteroid. Secosteroids would typically be expected to depress inflammation, | ||
+ | |||
+ | {{tag> |